What is the initial test for suspected pulmonary embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Testing for Suspected Pulmonary Embolism

Computed Tomography Pulmonary Angiography (CTPA) is the recommended initial lung imaging modality for non-massive pulmonary embolism (PE), following appropriate clinical probability assessment and D-dimer testing when indicated. 1, 2

Diagnostic Algorithm

Step 1: Clinical Probability Assessment

  • All patients with possible PE should have clinical probability assessed and documented using validated clinical prediction rules (Wells score or Geneva score) 2, 1
  • Categorize patients into low, intermediate, or high pretest probability of PE 1

Step 2: D-dimer Testing

  • For low pretest probability patients:
    • If all Pulmonary Embolism Rule-Out Criteria (PERC) are met: No further testing needed 1
    • If PERC criteria not all met: Proceed to D-dimer testing 1
  • For intermediate pretest probability patients:
    • Obtain high-sensitivity D-dimer measurement 1, 2
  • For high pretest probability patients:
    • Skip D-dimer testing and proceed directly to imaging 1, 2

Step 3: D-dimer Interpretation

  • For patients >50 years: Use age-adjusted D-dimer thresholds (age × 10 ng/mL) 1
  • If D-dimer is below threshold: No further testing needed 1, 2
  • If D-dimer is above threshold: Proceed to imaging 1, 2

Step 4: Imaging

  • CTPA is the recommended initial imaging test for patients requiring imaging based on clinical probability and D-dimer results 1, 2
  • Ventilation-perfusion (V/Q) scanning should be reserved for patients with contraindications to CTPA (severe renal failure, contrast allergy, pregnancy) 1, 2

Benefits of CTPA

  • High sensitivity (83%) and specificity (96%) 1
  • Allows visualization of pulmonary arteries down to the segmental level 1
  • Can identify alternative diagnoses in approximately 35% of patients without PE 1
  • Good interobserver agreement even with relatively inexperienced assessors 2

Special Considerations

For patients with clinical DVT

  • Leg ultrasound as the initial imaging test may be sufficient to confirm venous thromboembolism (VTE) 2
  • However, a single normal leg ultrasound should not be relied upon for exclusion of subclinical DVT 2

For massive PE

  • CTPA or echocardiography will reliably diagnose clinically massive PE 2
  • Imaging should be performed within 1 hour in massive PE 2

For pregnant women

  • Consider V/Q scan to reduce fetal radiation exposure 1

Common Pitfalls and Caveats

  • D-dimer testing should not be performed in those with high clinical probability of PE 2
  • A negative D-dimer test reliably excludes PE only in patients with low or intermediate clinical probability 2
  • CTPA may miss isolated subsegmental PE, with uncertain clinical significance 1
  • The negative predictive value of CTPA varies with clinical probability (96% in low probability patients but only 60% in high probability patients) 1
  • Hospitals should provide information on sensitivity and specificity of their D-dimer test 2

By following this evidence-based approach to diagnosing PE, clinicians can optimize patient outcomes while minimizing unnecessary testing and radiation exposure.

References

Guideline

Diagnostic Imaging for Pulmonary Embolism and Anastomotic Leaks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.